Cameron John Reynolds insider trades

Open-market stock purchases and sales by Cameron John Reynolds, President and CEO at Volitionrx Ltd, from SEC Form 4 filings since Aug 18, 2014.

Track record: 56% of 16 scored buys are up 5% or more since purchase, averaging +61%.

Recent trades

DateStockTradeValue
Feb 26, 2026VNRX Volitionrx LtdBought (not open market)—
Jan 22, 2026VNRX Volitionrx LtdBought (not open market)—
Nov 17, 2025VNRX Volitionrx LtdBought$7K
Oct 14, 2025VNRX Volitionrx LtdBought$1.1K

Companies traded

  • VNRX Volitionrx Ltd: 17 buys, 2 sales, last Feb 26, 2026

Get free alerts when Cameron John Reynolds files a new trade →